Breaking News

You are here » Indian-Commodity  :  Commodities  :  Jeera  :  Jeera futures trade marginally lower on profit booking

05-Sep2018

Jeera futures trade marginally lower on profit booking

Jeera futures traded marginally lower on NCDEX, as market participants booked their profits on weak advices from physical markets. Besides, sufficient stocks position following higher supplies from producing regions too fuelled the downtrend.

The contract for September delivery was trading at Rs 19265.00, down by 0.26% or Rs 50.00 from its previous closing of Rs 19315.00. The open interest of the contract stood at 4290 lots.

The contract for October delivery was trading at Rs 19690.00, down by 0.20% or Rs 40.00 from its previous closing of Rs 19730.00. The open interest of the contract stood at 4833 lots on NCDEX.



Related News

View all news

Jeera futures trade tad higher on firm demand

Jeera futures traded marginally higher on NCDEX, as market players initiated fresh buying counting on firm domestic and export demands in midst of diminished sowing reports. However, profit booking at......

Jeera futures trade lower on profit booking

Jeera futures traded lower on NCDEX, due to profit booking by participants after the prices peaked counting on improving physical domestic and exports demands from China and Bangladesh. Moreover, anticipation......

Jeera futures trade higher on firm demand

Jeera futures traded higher on NCDEX, due to scanty rainfall in producing centres of Gujarat and Rajasthan, which might impact cumin production this year. Moreover, firm spot demand from domestic......

Top News

View all news

Megastar Foods planning to incorporate subsidiary

Megastar Foods is planning to incorporate a subsidiary Company. The meeting of the Board of Directors of the company is scheduled to be held on November 27, 2018, to consider the same. Megastar Foods is......

Lupin launches generic Tetrabenazine Tablets

Lupin has launched Tetrabenazine Tablets, 12.5 mg and 25 mg having received an approval from the United States Food and Drug Administration (USFDA) earlier. Lupin's Tetrabenazine Tablets, 12.5 mg and 25......

UPL's arm signs definitive agreement to acquire entire stake of IBC

UPL's wholly owned subsidiary-- UPL Corporation, Mauritius has signed a definitive agreement to acquire directly or through its subsidiaries 100% of the shares of INDUSTRIAS BIOQUIM CENTROAMERICANA, SOCIEDAD......